
Edinburgh BioQuarter is a unique environment for innovation in healthcare by supporting intensive interactions between world-class clinicians, internationally renowned researchers and the global biomedical industry.
Its co-location is unique, creating an ideal environment for translational medicine. It is the only site in the UK that offers a world-class, state-of the art teaching hospital, the University of Edinburgh’s world-renowned Medical School and Research Institutes - including the new Scottish Centre for Regenerative Medicine, and a 140,000m2 science park all on the same site. The Centre for Regenerative Medicine is led by Professor Ian Wilmut, whose pioneering work captured the public’s imagination with the cloning of Dolly the Sheep in 1997.

BioQuarter is a major collaboration between Scottish Enterprise, the University of Edinburgh, NHS Lothian, the City of Edinburgh Council and Alexandria Real Estate Equities, Inc, working with Lothian University Hospitals NHS Trust. Alexandria Real Estate Equities Inc, the world’s leading life sciences property specialist, has a reputation for outstanding life science cluster development – including Mission Bay in San Francisco and MIT Technology Square in Cambridge, Massachussetts.
Edinbugh BioQuarter is located at Little France on the outskirts of Edinburgh. There are already several existing buildings on site, including the University of Edinburgh’s Medical School, the Queens Medical Research Institute and the Royal Infirmary of Edinburgh.
When complete the site will cover 100 acres and the centre will have more than 50,000m2 of academic research space and 90,000m2 available for commercial companies.
